My Pharmiweb.com (PharmiWeb) GxP Consulting Extends Portfolio With Increased Computer
My Pharmiweb.com (PharmiWeb)
GxP Consulting Extends Portfolio With Increased Computer Systems Validation Services Nottingham, UK, (May 11, 2009) - GxP Consulting, a leading provider of compliance services to the pharmaceutical and biopharmaceutical industries, today announces the addition of extended Computer Systems Validation (CSV) services to its portfolio.
US FDA approves pancreatic enzyme replacement product Creon (PharmaBiz)
The US Food and Drug Administration (FDA) has approved Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods.
FDA Approves Pancreatic Enzyme Replacement Product For Marketing In United States (Medical News Today)
The U.S. Food and Drug Administration announced that it has approved Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods.